The Practicality and Utility of Measured vs Estimated GFR in adCKD
NCT07450534 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-03-04
Summary
The goal of this observational study is to assess if new ways of measuring kidney function can better predict when individuals will become symptomatic due to kidney failure, and whether residual kidney function can be accurately measured in those already on dialysis.
The main questions the study is trying to answer is whether measuring kidney function by clearance of iohexol is comparable to the current standard of care methods.
In addition to routine care, participants will:
* undergo a brief clinical assessment
* be given an injection of iohexol and asked to perform 4 finger prick blood tests over 24 hours, recording the time of each sample. Samples will be returned in person or posted back
* be asked to complete a questionnaire on their experience
Conditions
- Chronic Kidney Disease (Stages 4 and 5)
- Chronic Kidney Disease 5D
Interventions
- DIAGNOSTIC_TEST
-
Iohexol Inj 300 MG/ML Diagnostic aid/agent used to measure glomerular filtration rate (GFR)
Injection of 3235mg iohexol (equivalent to 5ml Omnipaque 300) followed by serial dried blood spot testing over 24 hours to be measured for iohexol concentration and used to calculate clearance.
Sponsors & Collaborators
-
Manchester University NHS Foundation Trust
lead OTHER_GOV
Principal Investigators
-
Thomas Lindsay · Manchester University NHS Foundation Trust
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-02-28
- Primary Completion
- 2026-09-30
- Completion
- 2027-02-28
Countries
- United Kingdom
Study Locations
More Related Trials
-
Measuring the Plasma Clearance of Iohexol to Estimate Glomerular Filtration Rate in Intensive Care Unit Patients: Preliminary Feasibility Study
NCT02050269 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Examine Past Estimated Glomerular Filtration Rate (eGFR) Slope as a Risk Marker for Rapid Kidney Function Decline in People With Chronic Kidney Disease
NCT04881448 ·Status: TERMINATED ·Phase: PHASE2
-
Iohexol Clearance in Critically Ill Patients With Augmented Renal Creatinine Clearance
NCT04776486 ·Status: COMPLETED ·Phase: NA
-
Non-invasive Assessment to Predict Tolerance to Fluid Removal on Intermittent Kidney Replacement Therapy
NCT05270759 ·Status: COMPLETED
-
Intra Individual Evaluation of Uremic Toxin Levels in Hemodialysed Patients
NCT02480699 ·Status: COMPLETED ·Phase: NA
-
Development of a New Non-radioactive Test for Measuring Glomerular Filtration Rate Using the Tetrapeptide N-acetyl-Ser-Asp-Lys-Pro-amide (AcSDKP-NH2)
NCT01588756 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Percutaneous Nephrolithotomy in Patients With Stage 2-4 Chronic Kidney Disease
NCT04943081 ·Status: UNKNOWN ·Phase: NA
-
Clinical Performance of a Point-of-Care Creatinine Testing System in Individuals With Kidney Disease
NCT07251075 ·Status: NOT_YET_RECRUITING
-
Surveillance of HCV in Uremics and Linking to Medical Care
NCT03803410 ·Status: COMPLETED
-
Protocol to Assess the Severity of Acute Kidney Injury
NCT00673244 ·Status: COMPLETED ·Phase: NA
-
Study to Examine the Effect of the Diuretic Furosemide on the Plasma Levels of Toxins and the Removal of Toxins from the Blood in Patients with Chronic Kidney Disease
NCT06750575 ·Status: RECRUITING
-
Diuresis, Functional Bladder Capacity and LUTS in CKD and ESRD Patients.
NCT04622215 ·Status: COMPLETED ·Phase: NA
-
Clinical Outcomes of Hemodialysis in Brazil (COHEBRA): a Prospective Cohort Study
NCT05273424 ·Status: ENROLLING_BY_INVITATION
-
Exploring Approaches With Lower Targets of Blood Pressure and Lipid for Improving Renal Outcome in Advanced Chronic Kidney Disease
NCT06322056 ·Status: RECRUITING ·Phase: NA
-
Establishing a New Ultrasound Technique to Improve Assessment of Chronic Kidney Disease.
NCT06159439 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Observational Study in Patients With Autosomal Dominant Polycystic Kidney Disease
NCT01430494 ·Status: COMPLETED
-
Study of Urinary Angiotensinogen as a Marker to Warn the Deterioration of Renal Function in CKD Patients Early.
NCT01118494 ·Status: UNKNOWN
-
An Early Real-Time Electronic Health Record Risk Algorithm for the Prevention and Treatment of Acute Kidney Injury
NCT03590028 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Ultrasound Markers of Organ Congestion in Severe Acute Kidney Injury
NCT04095143 ·Status: COMPLETED
-
Roles of Uremic Toxins in Uremic Sacropenia
NCT03060590 ·Status: COMPLETED
-
Real World Evidence Clinical Utility Study of KidneyIntelX
NCT04802395 ·Status: RECRUITING
-
Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast
NCT04597892 ·Status: WITHDRAWN
-
Measurement of Iohexol Plasma Clearance in Patients Leaving ICU After Acute Renal Failure
NCT02961478 ·Status: COMPLETED ·Phase: PHASE3
-
Renal Function Measurements in Children
NCT01092260 ·Status: COMPLETED
-
Early Renal Replacement Therapy in COVID 19 Patients With AKI Does it Improve the Outcome?
NCT05274685 ·Status: COMPLETED ·Phase: NA